← Leaderboards
Faye A Rogers
Yale University
$3,808,947
Attributed
$3,808,947
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $796.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,808,947 · 5
By mechanism
R01$2,409,049 · 1
K22$553,143 · 1
P30$448,403 · 2
R21$398,352 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Mark J Shlomchik$51,286,869
- Akiko Iwasaki$25,435,081
- Erol Fikrig$57,005,638
- Joseph E Craft$42,575,841
- David M Rothstein$21,599,171
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsDesignDna DamageMalignant NeoplasmsSiteProteinsCellsRepairedComplexApoptosisDna RepairGenomeNucleotide Excision RepairStructureProgramsMolecularInsightLinkPositioning AttributeApoptoticDna LesionGenomic InstabilityMutagenesisCell Survival
Grant awards (15)
Role of XPD in DNA Damage Response Pathway Choice$388,181
R01 · FY2025 · GM · contact PI
Plan to Enhance Diversity$408,713
P30 · FY2024 · CA · contact PI
Role of XPD in DNA Damage Response Pathway Choice$388,181
R01 · FY2024 · GM · contact PI
Role of XPD in DNA Damage Response Pathway Choice$388,181
R01 · FY2023 · GM · contact PI
Role of XPD in DNA Damage Response Pathway Choice$102,575
R01 · FY2023 · GM · contact PI
Role of XPD in DNA Damage Response Pathway Choice$388,181
R01 · FY2022 · GM · contact PI
Role of XPD in DNA Damage Response Pathway Choice$376,875
R01 · FY2019 · GM · contact PI
Role of XPD in DNA Damage Response Pathway Choice$376,875
R01 · FY2018 · GM · contact PI
Gene-Targeted Apoptosis as a Treatment for HER2-Positive Breast Cancer$181,069
R21 · FY2016 · CA · contact PI
Gene-Targeted Apoptosis as a Treatment for HER2-Positive Breast Cancer$217,283
R21 · FY2015 · CA · contact PI
Altered Helical Structures: Repair and Induction of Genomic Instability$107,982
K22 · FY2009 · CA · contact PI
Altered Helical Structures: Repair and Induction of Genomic Instability$151,190
K22 · FY2008 · CA · contact PI
Altered Helical Structures: Repair and Induction of Genomic Instability$148,360
K22 · FY2007 · CA · contact PI
Improved Epidermal Gene Targeting Via Antigene$39,690
P30 · FY2007 · AR · contact PI
Altered Helical Structures: Repair and Induction of Genomic Instability$145,611
K22 · FY2006 · CA · contact PI